Portfolio company
Talisman Therapeutics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops human stem cell models of neurodegenerative diseases to provide drug discovery and target validation services for biotechnology and pharmaceutical organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Oscillution
This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.
Stemnovate
This company develops human cell-based platforms for drug discovery and toxicity testing to support pharmaceutical firms and research institutions.
Axol Bioscience
This company supplies human induced pluripotent stem cells and reagents to biopharmaceutical and academic organisations for drug discovery and disease modelling.
Bullseye Bio
This company develops vascularised organoids and automated screening platforms to provide drug discovery services for pharmaceutical, academic and biotechnology organisations.
Techbio 2.0
This company develops induced pluripotent stem cell models and artificial intelligence platforms to provide predictive drug discovery data for pharmaceutical and biotechnology researchers.
Mirae Cell Bio
This company develops stem cell therapies and transgenic animal models for pharmaceutical firms and medical researchers treating neurological and inflammatory diseases.
Savanna Biotherapeutics
This company develops induced pluripotent stem cell-derived microglia cell therapies to treat patients with neurodegenerative diseases and other central nervous system disorders.
Stemmaters
The company provides development and manufacturing services for regenerative medicine and cell therapy products to biotechnology and pharmaceutical clients.
